The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging.
Cosmai
Elizabeth M
EM
Division of Cardiology, Nuclear Cardiology Laboratory, Henry Low Heart Center, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA. ecosmai@harthosp.org
Heller
Gary V
GV
D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000150:complications / Q000175:diagnosis*; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D004562:Electrocardiography / Q000379:methods; D005080:Exercise Test / Q000379:methods*; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D014665:Vasodilator Agents; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis* / Q000209:etiology
D014665:Vasodilator Agents